“Outcome Optimization For Patients With Drug-Resistant Tb Via The Implementation Of An All-Inclusive Care Program” (2023) Journal of Pharmaceutical Negative Results, pp. 4001–4006. doi:10.47750/pnr.2023.14.03.504.